Invitrogen Overview
- Year Founded
-
1987
- Status
-
Acquired/Merged
- Employees
-
10,400
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
42
Invitrogen General Information
Description
Provider of genetic testing equipment and products intended to support biotechnological research. The company's genetic testing equipment and products include a range of differentiated reagents, kits, and benchtop devices that are easy to access and easy to buy, enabling laboratories to accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
Contact Information
Website
www.lifetechnologies.comCorporate Office
- 5791 Van Allen Way
- Carlsbad, CA 92008
- United States
Corporate Office
- 5791 Van Allen Way
- Carlsbad, CA 92008
- United States
Invitrogen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Invitrogen Comparisons
Industry
Financing
Details
Invitrogen Competitors (32)
One of Invitrogen’s 32 competitors is Condalab, a Corporation company based in Madrid, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Condalab | Corporation | Madrid, Spain | ||||
| Eurofins Genomics Europe Shared Services | Corporation | Ebersberg, Germany | ||||
| Editas Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Integrated DNA Technologies | Formerly PE-Backed | Coralville, IA |
Invitrogen Patents
Invitrogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202511746-D0 | Coated particles | Pending | 18-Jul-2025 | ||
| US-D1153780-S1 | Polymerase chain reaction instrument | Active | 09-May-2025 | ||
| WO-2026236250-A1 | Photoacoustic imaging compounds and methods of use | Pending | 06-May-2025 | ||
| WO-2026231630-A1 | Amplification-based optical calibration for digital polymerase chain reaction (dpcr) spectroscopy | Pending | 30-Apr-2025 | ||
| WO-2026231588-A1 | Methods of making site-specific activated antibodies and antibody conjugates | Pending | 29-Apr-2025 |
Invitrogen Signals
Invitrogen Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Invitrogen Investments & Acquisitions (42)
Invitrogen’s most recent deal was a Joint Venture with Huakang Smart Cloud. The deal was made on 01-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Huakang Smart Cloud | 01-Jun-2022 | Joint Venture | Systems and Information Management | ||
| Claritas Genomics | 18-Oct-2013 | Early Stage VC | Laboratory Services (Healthcare) | ||
| Life Science Korea | 13-Jun-2013 | Merger/Acquisition | Distributors/Wholesale | ||
| KDR Biotech Company | 12-Apr-2013 | Merger/Acquisition | Industrial Chemicals | ||
| BAC | 22-Jan-2013 | Merger/Acquisition | Biotechnology |
Invitrogen Exits (4)
Invitrogen’s most recent exit was on 18-Oct-2013 from Claritas Genomics. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Claritas Genomics | 18-Oct-2013 | Completed |
|
||
| SGB Biofuels | 17-Jan-2012 | Completed |
|
||
| SGB Biofuels | 14-Sep-2010 | Completed |
|
||
| Eurofins Genomics Blue Heron | 19-Dec-2006 | Later Stage VC | Completed |
|
Invitrogen Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Life Technologies Pension Plan | Carlsbad, CA | 1975 |
Invitrogen FAQs
-
When was Invitrogen founded?
Invitrogen was founded in 1987.
-
Where is Invitrogen headquartered?
Invitrogen is headquartered in Carlsbad, CA.
-
What is the size of Invitrogen?
Invitrogen has 10,400 total employees.
-
What industry is Invitrogen in?
Invitrogen’s primary industry is Biotechnology.
-
Is Invitrogen a private or public company?
Invitrogen is a Private company.
-
What is the current valuation of Invitrogen?
The current valuation of Invitrogen is .
-
What is Invitrogen’s current revenue?
The current revenue for Invitrogen is .
-
How much funding has Invitrogen raised over time?
Invitrogen has raised $5B.
-
Who are Invitrogen’s investors?
New Enterprise Associates and TA Associates Management have invested in Invitrogen.
-
Who are Invitrogen’s competitors?
Condalab, Eurofins Genomics Europe Shared Services, Editas Medicine, Adaptimmune Therapeutics, and Integrated DNA Technologies are some of the 32 competitors of Invitrogen.
-
When was Invitrogen acquired?
Invitrogen was acquired on 04-Feb-2014.
-
Who acquired Invitrogen?
Invitrogen was acquired by Thermo Fisher Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process